Philip Morris rises as IQOS regulatory clarity and smoke-free growth narrative stay in focus
Philip Morris International stock (PM) rose 3.0% due to renewed investor focus on U.S. regulatory clarity for its IQOS smoke-free products and the company's broader smoke-free growth strategy. The FDA recently reauthorized five IQOS products with exposure modification claims, allowing continued reduced-exposure messaging. This development, along with PMI's maintained adjusted EPS forecast and strong IQOS volume momentum, supports a higher valuation as regulatory uncertainty diminishes.
https://www.quiverquant.com/news/Philip+Morris+rises+as+IQOS+regulatory+clarity+and+smoke-free+growth+narrative+stay+in+focus